Erythropoietin 2000 IU Injection Price-Kexing Biopharm Supplier
Kexing Biopharm'S News About Exhibition Development And Awards
News And Information From Kexing Biopharm On The Drug Bevacizumab
Kexing Biopharm'S Video Center Talks About Corporate Trends
Kexing'S Recruitment Requirements Include Marketing Strategy Ability
Blog
Produce Protein Drugs And Microecological Preparations-Kexing Biopharm
Homemade Antiviral Interferon Manufacturer-Kexing Bioproducts
Kexing Biopharm Product Introduction 2026
Turn On The Genetic Engineering Drug Industry-Kexing Biopharm Factory
Corporate Culture-To Be The Leader Of High-Quality Biological Products
Kexing Biopharm Company Honors-Top 100 Private Enterprises In Jinan
Kexing Biopharm Marketing Features And Area-Global Market
Kexing Biopharm Platform Has Experience In Overseas Commercialization
Kexing Commercialization Capability-Perfect Overseas Business System
Produce Combined Clostridium Butyricum And Bifidobacterium Powder
Commercial Cooperation Graph-Global Commercial Cooperation Strategy
Kexing's Official Website Offer Professional Recombinant Protein Drugs
Kexing Biopharm Esg Includes Community Building And Environmental Protection
Kexing Quality System Includes Kexing Drug Development And Production
Kexing Biopharm Esg Includes Community Building And Environmental Protection
Kexing Biopharm Esg Includes Community Building And Environmental Protection
Kexing Production Capacity Up To 20 Billion Pieces Highly Complex Injections
Monitor Adverse Drug Reactions With Kexing Pharmacovigilance System
One Of Kexing Factory Global R&D Center-Kexing Guangzhou R&D Center
Kexing R&D Field Includes Pharmaceutical And Preclinical Research
Pseudorabies Virus Vector Vaccine-Innovative Animal Healthcare Company
High Quality Adalimumab Generic Price-Kexing Biopharm Manufacturer
Kexing Biopharm obtained the products of Trastuzumab and Neratinib Maleate Tablets
Bacteriophage Application Development And Manufacturing-Kexing
SITE MAP
Infliximab Biosimilar Price-Kexing Biopharm Manufacturer
Paclitaxel 300 Mg Injection Price-Kexing Biopharm Supplier
Southeast Asian Market Progress! Kexing Biopharm’s licensed-in product Infliximab Biosimilar Reminton Approved for Marketing in Thailand
Adalimumab Biosimilar Manufacturer and Supplier-Kexing Biopharm
Bevacizumab Biosimilar Price-Kexing Biopharm Manufacturer
Embracing Opportunities and Shaping the Future with Kexing ——Kexing Biopharm Shines at the 88th API China
Erythropoietin 4000 Injection Price-Kexing Biopharm Supplier
5-Aminnolevulinic Acid Supplier Manufacturer-Kexing Biopharm
Premium α-Ketoglutarate Price-Kexing Biopharm Factory
High Quality Entecavir Tablet Price-Kexing Biopharm Manufacturer
High Quality Kehuang Capsule - Kexing Biopharm Manufacturer
Human Interferon α1b For Injection-Kexing Biopharm Supplier
Combined Clostridium Butyricum and Bifidobacterium Capsule, Live
Human Granulocyte Colony-Stimulating Factor Drugs Manufacturer-Kexing Biopharm
Kexing Biopharm's Completion of the First Dose of Its Long-acting GC Product in Subjects in Phase 1 Clinical Study for In-depth Layout of WBC-Stimulating Drug Market
Kexing Biopharm Makes it into China's Top 20 Biopharmaceutical Enterprises (Blood Products, Vaccines and Insulin) for Two Consecutive Years
Led by Sci-tech Innovation, Expanding into Global Markets — Kexing Biopharm in International Exhibitions
Kexing Biopharm Attend the 5th Greater Bay Area Biopharmaceutical Innovators Summit
Going Global | Kexing Biopharm Expands Global Reach at the 2023 KIHE
Kexing Biopharm Holds China-MENA & South Asia Pharmaceutical Cooperation High-end Forum, Aiming at Foreign Emerging Markets
Kexing Biopharm Attended CPHI Worldwide 2023
Kexing Biopharm Introduces Eribulin Mesylate Injection, Expanding Its Overseas Product Portfolio
Breakthroughs in Kexing Biopharm's Overseas Efforts: Qualification of Two licensed Products for GMP Audits in Egypt
Completion of PIC/S Participating Authorities' Audits of Kexing Biopharm's licensed Product Infliximab for Injection
Kexing Biopharm Teams Up with Qingfeng Pharma for the Global Market on Olaparib Tablets
Kexing Biopharm Facility Passes EU GMP Certification for Paclitaxel for Injection (Albumin Bound)
Kexing Biopharm Obtained Clinical Trial Approval for its Self-developed Class I Innovative Drug--Long-acting Growth Hormone
Kexing Biopharm Introduces Eribulin Mesylate Injection, Expanding Its Overseas Product Portfolio
Kexing Biopharm Accelerates Global Commercialization with Successful INVIMA GMP Inspection
Kexing Biopharm's Albumin-bound Paclitaxel Granted EU Market Approval
2024 International Pharmaceutical Cooperation High-End Forum Kexing Biopharm's Series of Globalization Activities (China) Successfully Concluded
R&D Progress: Enrollment of Subjects in Phase III Clinical Trial for Inhaled Aerosol Drug in Children by Kexing Biopharm
Kexing Biopharm EU and US GMP Product Introduction_20251021
SANCTINUS-Kexing Biopharm
Recombinant Collagen Repair Mask Supplier-Factory-Kexing Biopharm
Recombinant Collagen Anti-Wrinkle Single Use Essence Supplier-Kexing Biopharm
World Inflammatory Bowel Disease Day | Healthy Gut, Happy Life
KexingBiopharm’s GB18 project received clearance of IND application from NMPA and FDA
Aflibercept Intravitreous Injection Supplier - Kexing Biopharm
Denosumab Supplier - First-Line Therapeutic Drugs for Osteoporosis - Kexing Biopharm
Enzalutamide Soft Capsules - A Novel Oral Androgen Receptor (AR) Inhibitor - Kexing Biopharm
Sitagliptin Phosphate Tablets - Oral Hypoglycemic DPP-4 Inhibitor- Kexing Biopharm
Liraglutide Injection - A Blockbuster Drug in the Field of Diabetes - Kexing Biopharm
Sevelamer Carbonate Tablets Supplier - Kexing Biopharm
Olaparib Tablets Supplier - Kexing Biopharm
Sorafenib Tablets Supplier - Kexing Biopharm
Eribulin Mesylate Injection Supplier - Kexing Biopharm
Neratinib Maleate Tablets Supplier - Kexing Biopharm
Lenalidomide Capsules Supplier - Kexing Biopharm
Trastuzumab Injection - Drug for full-course treatment of HER2+ breast cancer - Kexing Biopharm
Palbociclib Capsules Supplier - Kexing Biopharm
Semaglutide Injection Supplier - Kexing Biopharm
Kexing Biopharm and Easton Biopharmaceuticals Jointly Expand Overseas Market for Apalutamide Tablets
Government-Enterprise Synergy! Kexing Biopharm Represents Shenzhen Pharmaceutical and Medical Device Industry Overseas Expansion Consortium at Saudi Medical Device Industry Promotion Conference
Kexing Biopharm EU and US GMP Product List_20251022
Kexing Biopharm Product Catalog (Proprietary and Licensed-In Products)_20251021
Kexing Biopharm Product Introduction (Proprietary + Licensed-In Products)_20251021
Kexing Biopharm Product Introduction 20251021
Kexing Biopharm Partners with BioDlink to Embark on Latin American Markets
Kexing Biopharm’s Generic Paclitaxel (Albumin-bound) Approved in Uruguay
Kexing Biopharm's Licensed-In Generic Paclitaxel for Injection (Albumin-Bound) Receives Marketing Approval in Georgia
Kexing Biopharm's Ophthalmic Innovative Drug GB10 Research Featured in Prestigious International Journal
Kexing Biopharm's Licensed-In Product - Bevacizumab Receives Marketing Approval in Bolivia
Kexing Biopharm's Licensed-In Product – Neratinib Maleate Tablets Receives Marketing Approval in Indonesia
Kexing Biopharm's Licensed-In Product, Liraglutide Injection, Successfully Passed Brazil's ANVISA GMP On-Site Audit
Kexing Biopharm's Licensed-In Product – Liraglutide Injection Receives Marketing Approval in Peru
Kexing Biopharm's Licensed-In Product, Infliximab, Receives Marketing Approval in Malaysia
Kexing Biopharm's Independently Developed Ophthalmic Innovative Drug GB10 Receives Clinical Trial Approval
Kexing Biopharm Honored with the "Most Valuable Brand Award" at the 2025 Cailian Press Eighth Investment Annual Conference
Kexing Biopharm's GB19 Injection (SLE) Gets NMPA Approval for China Clinical Trials
Kexing Biopharm and Changzhou Pharmaceutical Factory Enter into European Commercialization Agreement for Two Cardiovascular Drugs
Kexing Biopharm's Liraglutide Biosimilar Receives ANVISA GMP Certification in Brazil
Kexing Biopharm Albumin-Bound Paclitaxel Approved in Asia Markets
Teriparatide Injection
Kexing Biopharm’s Innovative Drug GB19 Received Approval From FDA To Conduct Clinical Trials
Kexing Biopharm 's Overseas Commercial Product Albumin-Bound Paclitaxel with Marketing Approval in the Dominican Republic
Kexing Biopharm’s overseas commercial product, Albumin-bound Paclitaxel, has been approved for marketing in the Philippines.
Kexing Biopharm’s Overseas Products Bevacizumab and Sorafenib Approved for Marketing in Syria
Kexing Biopharm’s Overseas Product Paclitaxel for lnjection (Albumin Bound) Approved for Marketing in the UAE
Kexing Biopharm Enters Overseas Partnership with Daguang Pharmaceutical to Expand Global Eye Care Market
Kexing Biopharm Announces First Patient Dosed in Phase I Clinical Trial of Ophthalmology Innovative Drug GB10
Privacy Policy
May 19 World IBD Day | Five Years Together, Lighting the Way with Love
Kexing Biopharm Product List 2026
Kexing Biopharm Product Introduction 2026
Brand Value Recognized: Two Kexing Biopharm Trademarks Included in Guangdong Key Trademark Protection List
Kexing Biopharm’s Overseas Product Albumin-Bound Paclitaxel Receives Marketing Approval from Chile’s Regulatory Authority
Kexing Biopharm and Sinotherapeutics Reach Cooperation Agreement to Expand Overseas Markets for FDA-Approved Tofacitinib Product
Beyond Horizons , Forward Together | Kexing Biopharm Concludes Participation in CPHI & PMEC China 2026
Great News! Reminton® Receives Approval for Its Seventh Indication in China for the Treatment of Ulcerative Colitis in Children Aged 6 Years and Older
Kexing Biopharm’s Innovative Lupus Drug Completes First Participant Dosing in Phase I Clinical Trial
Kexing Biopharm's TL1A/LIGHT Bispecific Antibody Presents at 2026 BFC-Cytiva Global Healthcare Summer BD & Investment Conference
Kexing Biopharm’s Iicensed-in Bevacizumab Receives Marketing Authorization in Mexico
Kexing Biopharm and Xinhua Pharmaceutical Deepen International Cooperation to Advance a Cardiovascular Drug (High-Purity EPA) to Saudi Arabia and the UAE
Kexing Biopharm's Overseas Product Paclitaxel for Injection (Albumin-Bound) Receives Marketing Approval in Switzerland
Blog
Kexing Biopharm Deepens Its Presence in the Greater Bay Area Pharmaceutical Market as Three Partnered Products Receive Marketing Approval in Macao, China
The 1st China Pharmaceutical innovation Conference 2026 — Biosimilars Commercialization & Global Launch Session(China Focus) Concludes Successfully
Kexing Biopharm’s Jinan Pilot-Scale Platform for Protein Drugs Recognized as a 2026 Jinan Municipal Manufacturing Pilot Platform
Kexing Biopharm Partners with Visumpharma to Advance the Commercialization of Metoprolol Succinate Extended-Release Tablets in Hong Kong, China
Kexing Biopharm’s Albumin-Bound Paclitaxel Receives Marketing Authorization in Uzbekistan